Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Preferred Stock Series A	Common Shares	Treasury Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2023		$ 9,864	$ (1,199,337)	$ 36,208,728	$ (14,884,568)	$ 20,134,687
Balance (in Shares) at Dec. 31, 2023		9,864,120
Balance (in Shares) at Dec. 31, 2023			(641,963)
Stock-based compensation expense				151,412		151,412
Exercise of employee stock options		$ 15		39,757		39,772
Exercise of employee stock options (in Shares)		14,830
Net loss					(8,426,209)	(8,426,209)
Balance at Dec. 31, 2024		$ 9,879	$ (1,199,337)	36,399,897	(23,310,777)	$ 11,899,662
Balance (in Shares) at Dec. 31, 2024		9,878,950
Balance (in Shares) at Dec. 31, 2024			(641,963)			641,963
Issuance of Series A Preferred Stock	$ 4,000			8,196,000		$ 8,200,000
Issuance of Series A Preferred Stock (in Shares)	4,000,000
Repurchases of common stock			$ (301,048)			(452,306)
Repurchases of common stock (in Shares)			(151,258)
Stock-based compensation expense				343,850		343,850
Net loss					(1,956,536)	(1,956,536)
Balance at Dec. 31, 2025	$ 4,000	$ 9,879	$ (1,500,385)	$ 44,939,747	$ (25,267,313)	$ 18,185,928
Balance (in Shares) at Dec. 31, 2025	4,000,000	9,878,950
Balance (in Shares) at Dec. 31, 2025			(793,221)			793,221